PRR have a lot of potential, but it's very long term. There's others who are better investments atm, imho.
Market caps:
PRR $195m.
ACL $121m (large near term revenues, phase 3 trial to start soon too).
TIS $92m (commercialisation within months).
NEU $13m (two phase 2 trials running, both funded by third parties).
PRR became a darling because the sp kept rising. That adds fuel to the belief in the company. There's nothing wrong with that belief, the PRR drug looks great. It's just there is better short term potential elsewhere imho.
Good luck to holders
- Forums
- ASX - By Stock
- where to tomorrow
PRR have a lot of potential, but it's very long term. There's...
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
42.0¢ |
Change
0.025(6.33%) |
Mkt cap ! $598.3M |
Open | High | Low | Value | Volume |
39.5¢ | 42.0¢ | 39.5¢ | $890.1K | 2.163M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 127863 | 41.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.5¢ | 30850 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2700 | 0.405 |
4 | 77500 | 0.400 |
5 | 89711 | 0.395 |
9 | 535780 | 0.390 |
8 | 278921 | 0.385 |
Price($) | Vol. | No. |
---|---|---|
0.425 | 15972 | 1 |
0.430 | 114810 | 6 |
0.435 | 47564 | 2 |
0.440 | 51000 | 4 |
0.445 | 11000 | 2 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online